HDAC6 and Alzheimer disease: These results show that the inhibition of HDAC6 rescued neuronal cells from Aβ-induced impairment of mitochondrial axonal transport as well as mitochondrial length, identifying HDAC6 as a potential therapeutic target to modulate AD pathogenesis.